Antiepileptic drugs and markers of vascular risk - Wikidata - wikimedia - TriplyDB

Antiepileptic drugs and markers of vascular risk

Antiepileptic drugs and markers of vascular risk

http://www.wikidata.org/entity/Q34136014

about

Use of antiepileptic drugs and lipid-lowering agents in the United States.Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications.Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein Serum level of homocysteine, folate and vitamin-B12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.Enzyme induction with antiepileptic drugs: cause for concern?The long-term safety of antiepileptic drugs.Lamotrigine decreased hippocampal damage and improved vascular risk markers in a rat model of pentylenetetrazole induced kindling seizure.Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study.Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population.Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study.Late-onset seizures: a subclinical cerebrovascular disorder?Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study

P2860

Q33716490-FEC70EF4-7AC0-4F97-9582-4346D84617BD Q35960111-845A3F86-9CCE-4659-997B-E7113AA39A58 Q36110554-8D3A9DA3-9CA7-4E1F-90D9-3BCEAFAE2F61 Q36194833-F1678D3C-6CD7-4443-927A-33F3074E95BB Q36909520-AE1357A1-854D-41CD-A4FD-5DEE3DB7427E Q36923858-20C6A13A-8BFA-4999-9CA0-7332FB1A6832 Q37100709-C6D16B39-7D06-41DD-AA28-76A9753486EA Q38018125-0F474661-DD5E-41EB-BA20-9B3A98CAF35B Q38046892-8140B279-6570-4C7C-B83E-C2592BB7641C Q38106856-8951B73B-4257-4C5E-9CB2-C2E5559C7AAF Q41197531-F1CA5B23-E53E-492D-BA2B-0EE2BE9B226F Q46594751-8B89D26E-CC4D-4C6D-82EE-36670D2DE22F Q46986264-C4BBF97F-11E1-4DEC-A637-00C484E761F7 Q47142337-4B0984CE-A8C6-4C15-98DD-E3C5023F9359 Q47690803-FB9CA798-5CD8-478F-9249-99DF22FF1546 Q51358335-8718C480-666D-4AEC-AADB-9BEFFCB14551 Q51365311-0FDEA4F0-7431-4BEC-BA73-C0BEE84617FE Q55423163-69FA8E73-FA13-4C39-8749-F5144EFEA1DC Q56780998-18A9BC9E-7F81-40A5-820E-4ACA751A4B07 Q57260384-6F1C2860-802A-4945-B19D-D1D602B0920E

P2860

Antiepileptic drugs and markers of vascular risk

http://www.wikidata.org/entity/Q34136014

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antiepileptic drugs and markers of vascular risk

@ast

Antiepileptic drugs and markers of vascular risk

@en

Antiepileptic drugs and markers of vascular risk

@nl

type

label

Antiepileptic drugs and markers of vascular risk

@ast

Antiepileptic drugs and markers of vascular risk

@en

Antiepileptic drugs and markers of vascular risk

@nl

prefLabel

Antiepileptic drugs and markers of vascular risk

@ast

Antiepileptic drugs and markers of vascular risk

@en

Antiepileptic drugs and markers of vascular risk

@nl

P1433

Q34136014-1D13C12B-893B-4023-8E56-473EAF99CF6A

P1476

Q34136014-EE0AF823-3A72-4267-9EFF-7A6BAC9FD1E6

P2093

Q34136014-7AA528B2-B44D-4B6F-82A9-8A3D5DA6AD0F

Q34136014-7DB71E28-ED3B-4C55-8A9E-35F9737E97A1

P2860

Q34136014-092CA464-89B5-432A-9246-9DA557709765

Q34136014-0AE630F7-5F93-4AB3-B7E2-C8CBAE7D0C2B

Q34136014-1C4509F9-0486-4F4A-8124-A3F255B0B415

Q34136014-1FF0798A-D204-445D-93A7-5882FBDACEDC

Q34136014-37A8B056-1B6C-4C14-892A-5756AA03303F

Q34136014-4B17B4CA-4A9D-4668-ABB5-52EBA69AD297

Q34136014-564C9F99-A464-4C63-9712-EB4351880402

Q34136014-5A5A9D6B-F36D-44F8-AC77-515B5AED00A0

Q34136014-5CBC3C32-3097-4C17-903F-212250C37F1C

Q34136014-60319697-7216-4EB5-B71E-49F742203587

P2888

Q34136014-348F32DB-666E-4A07-ADBB-3CD1528D9A6F

P304

Q34136014-5BFA9D24-5981-48D5-8AF8-44BD82C303C5

P31

Q34136014-66255DFE-3A66-45E4-83CE-75B063519860

P356

Q34136014-ABE0681D-251A-4920-A65C-7D98E2AFF0AD

P433

Q34136014-1DCBD4C0-38E9-4FCB-8C7B-D0003607F269

P478

Q34136014-6DCA3CEE-F688-42A7-9B65-04A807D11C42

P577

Q34136014-EF675B08-4E83-48AF-B6FF-F65A222CDF01

P5875

Q34136014-0F228F08-5DA8-4719-AC35-CBA2FA101862

P698

Q34136014-91CF0289-C19F-47EB-910E-6609E266F92C

P932

Q34136014-73EE12D4-66C2-469A-AAB6-20E07AC0C4B7

P356

S11940-010-0080-Y

P1433

Current treatment options in neurology

P1476

Antiepileptic drugs and markers of vascular risk

@en

P2093

Carla Lopinto-Khoury

http://www.w3.org/2001/XMLSchema#string

Scott Mintzer

http://www.w3.org/2001/XMLSchema#string

P2860

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS).

Bodyweight gain and anticonvulsants: a comparative review.

Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.

The role of cytochrome P450 in the regulation of cholesterol biosynthesis.

Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.

P2888

s11940-010-0080-y

P304

300-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11940-010-0080-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46274323

http://www.w3.org/2001/XMLSchema#string

P698

20842589

http://www.w3.org/2001/XMLSchema#string

P932

2941234

http://www.w3.org/2001/XMLSchema#string